These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 33396966)

  • 1. Astroglial Connexin43 as a Potential Target for a Mood Stabiliser.
    Okada M; Oka T; Nakamoto M; Fukuyama K; Shiroyama T
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of 5-HT7 receptor inverse agonism of lurasidone on monoaminergic tripartite synaptic transmission and pathophysiology of lower risk of weight gain.
    Fukuyama K; Motomura E; Shiroyama T; Okada M
    Biomed Pharmacother; 2022 Apr; 148():112750. PubMed ID: 35219120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Atypical Antipsychotics, Clozapine, Quetiapine and Brexpiprazole on Astroglial Transmission Associated with Connexin43.
    Fukuyama K; Okada M
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brexpiprazole Reduces 5-HT7 Receptor Function on Astroglial Transmission Systems.
    Fukuyama K; Motomura E; Okada M
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct Effects of Escitalopram and Vortioxetine on Astroglial L-Glutamate Release Associated with Connexin43.
    Shiroyama T; Fukuyama K; Okada M
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an Atypical Antipsychotic, Zotepine, on Astroglial L-Glutamate Release through Hemichannels: Exploring the Mechanism of Mood-Stabilising Antipsychotic Actions and Antipsychotic-Induced Convulsion.
    Fukuyama K; Okada M
    Pharmaceuticals (Basel); 2021 Oct; 14(11):. PubMed ID: 34832898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connexin 43: insights into candidate pathological mechanisms of depression and its implications in antidepressant therapy.
    Zhang NN; Zhang Y; Wang ZZ; Chen NH
    Acta Pharmacol Sin; 2022 Oct; 43(10):2448-2461. PubMed ID: 35145238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and pharmacological inactivation of astroglial connexin 43 differentially influences the acute response of antidepressant and anxiolytic drugs.
    Portal B; Delcourte S; Rovera R; Lejards C; Bullich S; Malnou CE; Haddjeri N; Déglon N; Guiard BP
    Acta Physiol (Oxf); 2020 May; 229(1):e13440. PubMed ID: 31925934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders.
    Sanacora G; Banasr M
    Biol Psychiatry; 2013 Jun; 73(12):1172-9. PubMed ID: 23726152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astroglial connexin43 hemichannels tune basal excitatory synaptic transmission.
    Chever O; Lee CY; Rouach N
    J Neurosci; 2014 Aug; 34(34):11228-32. PubMed ID: 25143604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An astroglial basis of major depressive disorder? An overview.
    Wang Q; Jie W; Liu JH; Yang JM; Gao TM
    Glia; 2017 Aug; 65(8):1227-1250. PubMed ID: 28317185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astroglial connexin43 contributes to neuronal suffering in a mouse model of Alzheimer's disease.
    Yi C; Mei X; Ezan P; Mato S; Matias I; Giaume C; Koulakoff A
    Cell Death Differ; 2016 Oct; 23(10):1691-701. PubMed ID: 27391799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astroglial Connexin 43-Mediated Gap Junctions and Hemichannels: Potential Antidepressant Mechanisms and the Link to Neuroinflammation.
    Lei L; Wang YT; Hu D; Gai C; Zhang Y
    Cell Mol Neurobiol; 2023 Nov; 43(8):4023-4040. PubMed ID: 37875763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of Astroglial Cx43 Hemichannels to the Modulation of Glutamatergic Currents by D-Serine in the Mouse Prefrontal Cortex.
    Meunier C; Wang N; Yi C; Dallerac G; Ezan P; Koulakoff A; Leybaert L; Giaume C
    J Neurosci; 2017 Sep; 37(37):9064-9075. PubMed ID: 28821660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astroglial Connexins Inactivation Increases Relapse of Depressive-like Phenotype after Antidepressant Withdrawal.
    Portal B; Vasile F; Zapata J; Lejards C; Ait Tayeb AEK; Colle R; Verstuyft C; Corruble E; Rouach N; Guiard BP
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avoiding drug-induced switching in patients with bipolar depression.
    Henry C; Demotes-Mainard J
    Drug Saf; 2003; 26(5):337-51. PubMed ID: 12650634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cytokine-induced connexin43 hemichannel activity in astrocytes is neuroprotective.
    Froger N; Orellana JA; Calvo CF; Amigou E; Kozoriz MG; Naus CC; Sáez JC; Giaume C
    Mol Cell Neurosci; 2010 Sep; 45(1):37-46. PubMed ID: 20684043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The monoaminergic tripartite synapse: a putative target for currently available antidepressant drugs.
    Quesseveur G; Gardier AM; Guiard BP
    Curr Drug Targets; 2013 Oct; 14(11):1277-94. PubMed ID: 24020973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.
    Sanacora G; Treccani G; Popoli M
    Neuropharmacology; 2012 Jan; 62(1):63-77. PubMed ID: 21827775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological brain changes in depression: can antidepressants reverse them?
    Miguel-Hidalgo JJ; Rajkowska G
    CNS Drugs; 2002; 16(6):361-72. PubMed ID: 12027783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.